The 340B Drug Pricing Program: A Small Part of the Prescription Drug Market, Delivering Large Benefits to Patients and Communities
Link
Description
Analyzes impacts of the 340B Drug Pricing Program on access, hospital finance, drug companies, and public expenditures. Discusses how the 340B program is shaped by legislation, policy, finance, prescribing patterns, and market influences. Highlights rural and underserved communities throughout.
Date
03/2024
Type
Document
Organization
American Hospital Association
Tagged as
Access · Healthcare business and finance · Hospitals · Legislation and regulations · Pharmacy and prescription drugs · Reimbursement and payment models · Statistics and data